Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 7, Number 6—December 2001


Legionella-Like and Other Amoebal Pathogens as Agents of Community-Acquired Pneumonia

Thomas J. Marrie*Comments to Author , Didier Raoult†, Bernard La Scola†, Richard J. Birtles†, Emidio de Carolis‡, and the Canadian Community-Acquired Pneumonia Study Group
Author affiliations: *Department of Medicine University of Alberta, Edmonton, Alberta, Canada;; †Faculté de Médecine de Marseille, Marseille, France;; ‡Pfizer Canada Inc., Montreal, Quebec, Canada

Main Article

Table 2

Summary of selected characteristics of four patients infected with Legionella-like amoebal pathogen (LLAP)-4

No. Age Sex Temp Symptoms LOS WBC Antibiotics Comments Antibody titer Co-pathogens
TM37 93 M 38.3 nausea, myalgia, shortness of breath, nonproductive cough, chest pain 8 18.2 erythromycin; cefuroxime admitted from a nursing home, sustained a non q wave myocardial infarction IgG 1:400 and 1:400 None
TM11 87 F 39.0 nonproductive cough, chills 11 8.7 erythromycin; cefuroxime IgG 0 and 1:100 None
ML13 54 M 38.4 abdominal pain, nonproductive cough, myalgia, chest pain 17 2.2 erythromycin; ceftazidime, ribavirin bone marrow transplant; required intensive care unit treatment IgM 25 and 0; IgG 200 and 1:400 RSV
LN 9
shortness of breath, chills
erythromycin, cefuroxime

IgM 1:200 and 1:200
Strepto-coccus pneumoniae

M = male; F = female; LOS = length of stay in days; wbc = leukocyte count; antibody titer = first value is from acute-phase sample and second from convalescent-phase sample.

Main Article

1R. Duperval, S. Field, T. Louie, S. Houston, M. Gribble, K. Williams, L. Nicolle, R. Grossman, I. Salit, R. Saginur, D. Gregson, M. Laverdiere, Jean Joly, T. Marrie, and J. Hutchinson.